Newsroom | 2221 results
Sorted by: Latest
-
Riassunto: Eurofins Viracor BioPharma amplia le proprie capacità bioanalitiche
LUSSEMBURGO--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, partner di lunga data e affidabile per le soluzioni di studi clinici con una vasta esperienza nell'ambito di biomarcatori specifici e test molecolari, ha annunciato un'importante espansione del proprio portafoglio di servizi con l'aggiunta di capacità migliorate di test bioanalitici. Questi nuovi servizi sono in completa sintonia con le buone pratiche di laboratorio (GLP) e le buone pratiche cliniche (GCP), e consentiranno all'a...
-
Eurofins Viracor BioPharma erweitert bioanalytische Fähigkeiten
LUXEMBURG--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, ein langjähriger und bewährter Partner für klinische Testlösungen mit fundierter Expertise in den Bereichen Spezialbiomarker und molekulare Assays, gibt eine bedeutende Erweiterung seines Serviceportfolios um zusätzliche bioanalytische Testkapazitäten bekannt. Diese neuen Serviceleistungen erfüllen die GLP- (Good Laboratory Practices) und GCP-Anforderungen (Good Clinical Practices) und helfen Unternehmen, die Unterstützung von bio...
-
Eurofins Viracor BioPharma étoffe ses capacités bioanalytiques
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, partenaire de longue date et de confiance dans le domaine des solutions de tests cliniques, jouissant d'une expertise approfondie dans les biomarqueurs spécialisés et les tests moléculaires, annonce une expansion significative de son portefeuille de services avec l'ajout de capacités de tests bioanalytiques améliorées. Ces nouveaux services s'inscrivent pleinement dans le cadre des bonnes pratiques de laboratoire (BPL) et des bon...
-
Resumen: Eurofins Viracor BioPharma amplía sus capacidades bioanalíticas
LUXEMBURGO--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, un socio confiable para las soluciones de ensayos clínicos desde hace mucho tiempo que tiene una amplia experiencia en biomarcadores de especialidad y ensayos moleculares, anunció una gran ampliación de su cartera de servicios con la incorporación de capacidades avanzadas de pruebas bioanalíticas. Estos nuevos servicios están totalmente alineados con las Buenas Prácticas de Laboratorio (BPL) y las Buenas Prácticas Clínicas (BPC),...
-
Samenvatting: Eurofins Viracor BioPharma breidt bioanalytische capaciteiten uit
LUXEMBURG--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, reeds geruime tijd een vertrouwde partner voor oplossingen ten behoeve van klinische studietesten met grondige expertise in gespecialiseerde biomarkers en moleculaire proeven, kondigt een belangrijke uitbreiding van haar serviceportfolio aan met de toevoeging van verbeterde bioanalytische testcapaciteiten. Deze nieuwe services zijn volledig in lijn met GLP (Good Laboratory Practices) en GCP (Good Clinical Practices), zodat het bed...
-
NextSense Launches Smartbuds, the World's First Truly Wireless EEG Earbuds — Brain-Sensing Technology That Actively Improves Sleep
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NextSense, a pioneer in brain-sensing wearable technology, today announced the official launch and commercial shipping of NextSense Smartbuds. Unlike sleep trackers that only monitor, Smartbuds use six EEG sensors to measure brain activity in real time — then respond with precisely timed audio stimulation to guide the brain into deeper, more restorative sleep. By transforming EEG from a clinical tool into an effortless consumer experience, NextSense redef...
-
Eurofins Viracor BioPharma Expands Bioanalytical Capabilities
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant expansion of its service portfolio with the addition of enhanced bioanalytical testing capabilities. These new services are fully aligned with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), enabling the company to enhance support of biopharmaceutical...
-
Trividia Health, Inc. Initiates Labeling Correction for all TRUE METRIX® Blood Glucose Monitoring Systems
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--Trividia Health, Inc., announced today that it is initiating a labeling correction which requires a modification of the Owner’s Booklets/System Instructions for Use for all TRUE METRIX, TRUE METRIX AIR, TRUE METRIX GO, and TRUE METRIX PRO Blood Glucose Monitoring Systems (collectively, the “Products”) distributed in the United States, United Kingdom, Mexico, Australia, and the Caribbean. Trividia is updating the E-5 Error Code in the “Messages” section of...
-
National Supplemental Screening Program Celebrates 20 Years of Service; Eligible Individuals Encouraged to Participate
OAK RIDGE, Tenn.--(BUSINESS WIRE)--The U.S. Department of Energy (DOE) National Supplemental Screening Program (NSSP), managed by ORAU, is celebrating 20 years of continued service and encourages those eligible to participate in the program. The NSSP, part of the DOE Former Worker Medical Screening Program (FWP), offers medical screening exams at no cost to DOE former federal, contractor and subcontractor workers who may be at risk for occupational diseases. To date, more than 25,000 individual...
-
Press Ganey and Compass Healthcare Launch New e-Book: “Intelligence with Empathy: Building the future of compassionate care”
ATLANTA--(BUSINESS WIRE)--Press Ganey and Compass Healthcare released a new collaborative e-book, “Intelligence with Empathy: Building the future of compassionate care.”...